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immunization markedly enhance the degree of contact sensitiv-
ity in sensitized animals a nd reverse tolerance in unl'esponsive 
animals [20-22]. 
In the present study, we observed that the unl'esponsiveness 
obtained by topical application of DNCB on PUV A-treated 
skin was also reversed by intraperitoneal administration of 
cyclophosphamide. Consequently it can be assumed that the 
tolerance in t hese animals is also a specific immunologic unre-
sponsiveness media ted by suppressor cells. Recently we con-
firm ed in mice tha t the unresponsiveness can be transferred to 
syngeneic recipients using spleen cells and that the suppression 
by spleen cells was a brogated by antibody to T cell-specific 
antigen (Thy 1.2) and complement treatm ent (unpublished 
data) . 
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The ability to activate complement in human serum 
was evaluated for the two yeast-like urganisms Pityros-
porum orbiculare, the presumed etiologic agent of tinea 
versicolor, and Candida albicans. Complement activa-
tion was measured by: (a) using inhibition of rabbit red 
blood cell lysis by human serum after incubation with 
the organisms, and (b) quantitation of the amount of C3 
deposited on the surface of the yeast by an enzyme-
linked immunoabsorbent assay. It was found that both 
organisms had approximately equal ability to activate 
complement in normal serum or serum having only the 
Manuscrip t received December 14, 1981; accepted for publication 
June 11, 1982. 
This work was supported by the Veterans Administra tion and by 
Grant AI-16559 from the National Institutes of Health. 
Reprin t requests to: Dr. Peter G. Sohnle, Research Service/ l 51. 
alternative pathway intact, even though extracts of C. 
albicans contained significantly greater amounts of both 
carbohydrate and antigenic material capable of combin-
ing with the antibody present in normal human serum. 
The marked difference in inflammation in the cutaneous 
lesions produced by these two organisms does not ap-
pear to be related to their complement-activating ability 
and is more likely due to some other factor such as 
differences in invasiveness or in ability to elicit other 
immunologic reactions. 
Veterans Administration Medical Center, Woorl , Wisconsin 53193. 
Abbreviations: 
EGTA: ethylene glycol-bis-( beta-amino ethyl ether)-N ,N'- t.etra-
acetic acid 
ELISA: enzyme-linked immul1oabsorbent assay 
PBS: phosphate-buffered saline 
RBC: red-blood cells 
94 SORNLE AND COLLIN S-LECR 
T inea versicolor is a superfic ial fungal infection that evokes 
very lit tle in fla m matory resp o nse by t h e host. In con trast, 
s uperficial c u taneous infections with Candida albicans a r e 
highly infla m matory, producing n e u t r ophil-con taining epider-
mal m icroabscesses in acu te infectio ns [1] a nd marked d ermal 
mono n uclear cell in fll tratio n in chronic infection s [2]. Comple -
ment activatio n via th e alternative pathway h as been impli-
cated in t h e production of t h e former ty p e o f infla mmat ory 
r eactio n to cu tan eous Cand ida infections [3]. However , t h e 
inflammatio n produced in an oth er type o f superficia l mycosis, 
i.e., exp erimental cu taneous Trichophyton m en tagrophytes in-
fection , appears to be d u e mainly to cell-m ediated immunity 
[4]. In a n att empt to elucidate t h e d iffer e n ces in cap acity to 
produ ce inflammatio n of Candida a nd P ityrosporum orbicu-
lare (th e apparen t etiologic agent o f tinea versicolor) , w e h a ve 
previously com pared t h e a n t igenicity of t h e tw o orga nis m s in 
lymphocyte tran sform ation tests. These experiments d e m o n-
strated that Candida was significantly more a n tigenic t h a n was 
Pityrosporum in t his system [5]. 
Complemen t activatio n m ay be involved in microa bscess 
form atio n , and Candida infectio ns are associa t ed with t his type 
of acu te infil trate wh ereas infectio ns caused by Pityrosp orum 
are not. T h er efor e, t h e presen t study was design ed to compare 
complemen t activation by t h e two or ganism s. Pityrosporum is 
a yeast-like organism t h at h as a n absolute growth r equire m en t 
for added lip ids in vitro. I n p r evio us studies, w e h ave fo und t h at 
most of t h e yeast grown in a 2-phase sys t e m will becom e 
ph ysically associated wit h th e oil [5]. The refore , this or ganis m 's 
sUl'face m igh t be con sid erably differ e n t from t hat o f Cand ida 
a nd t hus less able to activate comple m e n t a nd elicit acu te 
infl ammation . 
MATERIALS AND METHODS 
Organisms 
Five isolates of P. orbiculare were obtained from skin scrapings of 
tinea versicolor lesions by cu lt UJ"e on mycosel agar (BBL, D iv. Becton, 
Dickinson, and Co., Cockeysville, Mru·ylan d) overla id with sterile olive 
oil . Subcul tures were made f!"Om emerging colonies and identilied as P. 
orbiculare by morphologic appear ance a nd a strict requirement for 
added lipid. All 5 isolates grew preferent ia lly at the oil- water in te rface 
of broth cultures, although 2 a lso grew in t he water phase a nd could be 
centri fuged free of oi l if 0.1% Tween 80 were added to the medium. 
Five isolates of C. albicans were obtained from clinical isolates a nd 
ma intained by repeated passage on Sabouraud's agar. Both organisms 
were grown in bul k in AOAC synthetic broth (Difco Laboratories, 
Detroit, Michigan) containing 1% dextrose, chloramph enicol (20 f1.g/ 
ml) , cycloheximide (250 f1.g/ml), 0.1 % T ween 80, and overlaid wi th 
sterile olive oil. At the end of the cul ture period (14 days for P. 
orbiculare and 5 days fo r C. albicans), the oil and water phases were 
separated by centrifugation and the organisms in the water phase 
washed 3 times in 0.9% NaCI. T he quantity of organisms present was 
expressed as either ml of packed cells or as dry weight dete rmined a fter 
lyophilization of t he yeast suspensions. These two methods were used 
in case one or the other a lone might have given a n inaccurate estimate 
of the quantity of organisms p resent. 
Preparation of Ext.racts 
Extracts of the ·two organisms were prepared as described previously 
[5] using either t he ether extraction method or sonication. P rotein 
concentrations of the extracts were determined by the Lowry techniqu e 
a nd carbohydrates by the ac id-phenol method [6]. 
Measurement of Complement Activation Using Hemolysis of R abbit 
Red Blood Cells (RBC) 
Human sera were incubated with known· quantities of yeast or yeast 
extracts and then evaluated fo r their ability to hemolyze ra bbit RBC 
by the alte rnative pathway using a modification of the method of 
Platts-Mills and Ishizaka [7). In brief, the yeast or yeast extracts were 
incubated for 30 min at 37°C with normal human serum, human serum 
with 5 X 10-" Methylene glycol-bis-(beta-amino ethyl ether)-N,N'-
tetraacetic acid (EGTA) conta ining 5 X 10-" M of MgCI2, or C2-deficient 
human serum (kindly provided by Dr. S usan Koethe, Medical College 
of Wisconsin). T he yeasts were removed by centrifugation, a nd the 
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serum was then incubated at a 1:5 dilution with rabbit R BC that had 
been obtained in heparin and then washed and suspended to approxi-
mately 1.5 X lOB ceLls/ml of gelatin-verona l-saline at pH 7.6 conta ining 
5 >< 10- " M EGTA and 5 X 10- " M MgCb. T he incubation was a llowed 
to proceed for 2 hr at 37°C, after which t ime 2.5 ml of 10- 2 M EGTA in 
saline was added. 
The tubes were then cen trifuged and the resulting supernatants read 
at 413 nm in a spectrophotometer . The results were compared to those 
from samples in which 100% RBC lysis was obtained with distilled 
water. Resul ts were expressed as percent inhibi t ion of hemolys is as a 
function of either the dry weight or packed volume of organisms 
employed. The a mount required to produce 20% or 50% inh ibition of 
hemolysis was obtained using a series of dilu t ions of the yeast suspen-
sion. 
Measurement of Complement. Acti vation by Qua.ntitating C3 Dep osi-
tion on the Y east S urface 
An enzyme-linked immunoa bsorbent assay (ELISA) was developed 
to measure the amount of C3 deposited on known quant it ies of yeast 
during incubation wi th the 3 human serum preparations used above. 
Various dilu tions of yeast suspensions were first heated to 100°C for 60 
min to remove endogenous peroxidase activity and then incubated in 
0.1 ml volumes wi th 0.1 mI of serum for 30 min at 37°C. The yeast was 
next washed 3 t imes in 0.05 M phosphate-bu ffered saline (PBS) con-
ta ining 0.05% Tween 20. They were then incubated wi th 0.5 ml of a 
1:1000 dilu t ion of peroxidase-conjugated goat a ntihuma n C3 (CappeU 
Laboratories, Cochranville, Pennsylvania ) for 30 min at 37°C and again 
washed 3 t imes wi th PBS-Tween 20. After removal to a fresh test tube, 
1.0 ml of substrate was added (1 mg/ ml O- phenylenedia mine, Eastma n 
Koda k Co., Hochester, New York, in 0.05 M citra te buffe r , pH 4.5, and 
0.05% H,0 2). After 40 min of incubat ion at room temperatw·e, the 
supernatants were separated by cent rifugation and read in a spectro-
photometer at 420 nm. Data were expressed as opt ical density t imes 
1000 per f1.g of yeast. 
Determination of A ntigen Content in Yeast. Extracts by Inhibition of 
Antibody Activit.y 
An ELISA-type antibody assay was set up for determining ant ibody 
activi ty against extracts of C. albicans a nd P . orb iculare in norma l 
human serum . Polysty rene tubes were coated with 1.0 ml of appropriate 
dilu t ions of either extract in 0.05 M PBS at pH 7.6 fo r 1 hr at room 
temperature. The tubes were washed 3 t imes wi th PBS-Tween 20, 
treated with 1% bovine serum albumin, a nd washed again. Following 
this step, 0.5 ml of a 1:50 dilu t ion of a pool of serum 1'rom 10 normal 
subjects was added and incuba ted at 37°C for 30 min. The tubes were 
washed 3 t imes wi th PBS-Tween 20, and 0.5 ml of a 1:200 dilu t ion of 
peroxidase- la beled, a ffini ty-purified goat ant ihuman IgG (Li tton B io-
netics, Kensington, Maryland) was added. After incubation for 30 min 
at 37°C, the tubes were again washed 3 t imes wi th PBS-Tween 20, and 
1.0 ml of the substrate described a bove was added . The tubes were 
incubated for 40 min and read at 420 nm. Bla nks were set up without 
the human serulTI and these va lues sub t racted from the experimenta l 
values. The experiments were cruTied out by incubating the pooled 
human serum with various amounts of 4 extracts each of C. albicans 
and P. orbiculare and then testing the serum for residua l antibody 
activity against the corresponding organism. The resul t ing percent 
inhibi tion of the opt ical density obtained was plotted against the 
quantity of extract employed (based on protein plus carbohydrate 
content) to lind the amount necessary for 50% inhibi t ion. 
Controls for the spec ificity of the peroxidase- la beled antihuman 
heavy-chain reagents were carried out in our system as fo llows: purified 
immunoglobulins of the 3 classes (CappeLl Laboratories, Cochranville, 
Pennsylvania ) were coated onto plastic tubes at a concentration of 10 
f1.g/ml, washed, a nd incubated with dilu t ions of the 3 peroxidase- labeled 
reagents. Good agreement was obtained between the stated specificity 
and actua l antibody activity aga inst the appropr iate immunoglobulin 
class in this test. 
Human Sera 
Three sera from normal persons and one fTom an otherwise normal, 
but C2-deficient person were used for the studies of complement 
activation. These sera were stored in a liquots at -70°C. The pool of 
norma l sera was prepru·ed using equa l volumes of serum from 10 norma l 
subjects without a history of superficial fungal infections. These sera 
were kept at -20°C. We have previously demonstra ted that normal 
human serum has a nt ibody aga inst Pityrosp orum as well as Cand ida 
[8). 
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Statistics 
In the complement assays, 4 different yeast preparations represent-
ing 2 isolates each of the two organisms were used. For the studies 
comparing protein and carbohydrate contents of extracts, 6 ether 
extracts and 4 sonicates were tested, representing 5 isolates of each 
organism in all The extracts that were used in t he studies of antigen 
content and complement-activating a bili ty consisted of 2 ether extracts 
and 2 sonicates representing 2 isolates of each organism. Comparisons 
were made between the various groups using the unpaired, two-ta iled 
t-test. 
RESULTS 
Complement Activation by C. albicans and P . orbiculare 
In Table I , the ability of the two organisms to activate 
complemen t is expressed as th e percent inhibit ion of rabbit 
RBC hemolysis after incubation of 5.0% and 0.5% yeast suspen-
sions with the serum. No significant differences were found 
between the two organisms at either concentration using normal 
serum or serum lacking the classical pathway by virtue of 
calcium chelation or C2 deficiency. Similar results were ob-
tained when the yeasts were quantified after lyophilization of 
aliquots and weighing (results not shown). It should be noted 
that h emolysis by C2-deficient serum was affected less by 
incubation with th e two yeasts or with inulin than was normal 
serum with or without Mg-EGTA. This finding may be related 
to the mildly deficient function of C2-deficient serum in this 
system as has been r eported previously .[9]. As shown in Table 
II, heating at 56°C for I/~ hr significantly suppressed t he ability 
of either normal or C2-deficient serum to cause hemolysis of 
rabbit RBC. 
The a bility of extracts of t he two organisms to activate 
complement was also evaluated using the rabbit RBC system. 
TABLE I. Percent inhibition of rabbit REC hemolysis by hu.man 
serum, complement u.sing constant volumes of yeast 
Serum 
5,0% yeast by volume 
(mean ± SE of % inhibition) 
Candida 
(N = 4) 
N ormal 91.0 ± 2,7 
Normal + Mg-EGTA 83,5 ± 6,1 
C2-deficient 33.8 ± 10.4 
0.5% yeast by volume 
(mean ± SE of % inh ibition) 
Normal 30.5 ± 2. 1 
Normal + Mg-EGTA 32,8 ± 11 ,3 
C2-deficient 1.0 ± 0,6 
P':ly rosporu m. 
(N = 4) 
85.3 ± 2,7 
86.8 ± 2,0 
49.8 ± 9,0 
26,8 ± 3.2 
34.3 ± 12.1 
6,0 ± 1.5 
Statistica l 
s ignifica nce 
NS 
NS 
NS 
NS 
NS 
p < ,02 
Note: Inulin at 10 mg/ ml produced 94% suppression of hemolysis 
using normal seru m, 95% using normal serum + Mg-EGTA, and 28% 
using C2-deficient serum, 
TABLE II. Comparison of unheated serum vs. serum heated at 56°C 
for 30 /II,in. in. the assays of complemeniactivation 
Rabbit REC Hemolysis 
Unheated Heated Percent of Serum (% lysis ) (% lysis) activity remaining 
Norma l 74.1% 1.7% 2.3% 
C2-deficient 58.8% 2.4% 4,1% 
C3-0eposition on Yeast Surface as Measured by the ELISA Assay 
Serum 
Candida 
Normal 
C2-deficient 
Pityrosporwn 
Normal 
C2-deficient 
Unheated 
(00 X 1000) 
770 
470 
947 
782 
H eated 
(00 X 1000) 
60 
63 
138 
163 
Percen t of 
activity 
remaining 
7,8% 
13.4% 
14,6% 
20.8% 
These data are from 1 representative experimen t of 3 that were 
performed. 
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TABLE III, Percent inlu:bition of rabbit REC hemolysis by human 
. serum. using 500 /lg/m.l of yeast extracts 
Extract" 
Sl 
S2 
E1 
E2 
S l 
S2 
E1 
E2 
Candida PityroHpOrU11l 
Normal hum.an serum 
22.2" 
27.7 
11.1 
12.4 
Norm.al human serum + Mg-EGTA 
26,7 
38.0 
2,0 
2.0 
25,0 
7.0 
0,0 
0.0 
20.4 
7.8 
5.4 
22.3 
" Extracts represent 2 sonicates (Sl and S2) and 2 ether extracts (E1 
and E2) of each organism, 
" Dat.a represent % inhibition of hemolysis aft.er incubation with 500 
/lg / ml of the indicated extract .. 
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FIG 1. Deposition of C3 on the surface of C. albicans and P. o/'b i-
culare (4 isolates each) using normal human serum, normal human 
seru m plus Mg-EGTA, or C2-deficient human serum, Deposition of C3 
was determined using an ELISA system as out lined in Mate rials and 
Methods and the results expressed as optical density x 1000/ /lg of 
yeast. The differences in C3 deposition were not significan tly different 
for the two types of yeast with any of the 3 t.ypes of serum, For 
Candida, but not Pityrosporwn, there was a significant difference 
between C3 deposition using normal serum vs. either Mg-EGTA-
treated serum or C2-deficient serum (p < 0,02 in both cases). 
Two ether extracts and 2 sonicates of each organism were tested 
in this system at a concentration of 500 flg / ml (combined 
protein and carbohydrate contents), the approxin1ate amount 
at which whole yeast produced 20% inhibition of hemolysis 
after incubation with the test serum. As shown in Table III, th e 
results were quite variable, although some complement-acti-
vating ability was evident for some of the extracts. 
Complement activation was a lso measured by determining 
the amount of C3 deposited on the yeast cell surface. This 
technique was developed because of the possibility that inhi-
bition of rabbit RBC lysis by the yeast could have been due to 
an actual complement inhibitor of some kind rather than to the 
consumption of complement components by t heir activation. 
As shown in Fig 1, th ere ar e no significant differences in the 
amount of C3 deposited on the sw-face of the two organisms 
after incubation with human serum. It would appeal' that more 
C3 is deposited on the yeast swface if serum with an intact 
classical pathway is used. The difference between th e r esults 
obtained with normal serum vs. that treated with Mg-EGTA or 
C2-deficient serum was significant for Candida (p < 0.02 in 
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TABLE IV. Protein and carbohydrate contents o(Candida and 
Pityrosporum extracts 
Organism Protein Carbohydrate Protein/ carbohydrate 
Sonicates" 
Candida 9.30± 0.82 13.58 ± 3.75 0.93 ± 0.34 
Pityrosporum 4.71 ± 1.76 1.44 ± 0.68 3.54 ± 0.43 
Statistical sig- 0.1 > p > 0.05 p < 0.02 p < 0.01 
nificanceb 
Ether extracts" 
Candida 3.57 ± 1.21 5.67 ± 1.30 0.80 ± 0.37 
Pityrosporum 2.57 ± 0.61 0.69 ± 0.13 3.94 ± 0.77 
Statistical sig- NS p < 0.01 p < 0.01 
nificance" 
" Comparisons were made between protein and carbohydrate con-
tents (expressed as mg/ml of organisms ± S.E.) for 4 sonicates and 6 
ether extracts of each organism. 
" Statistical significance by the unpaired, two-tailed I-test was taken 
atp < 0.05. 
TABLE V. Antigenic activity o(Candida and Pityrosporum extracts 
in an ELISA assay 
Organism 
Candida 
Pityrosporum 
Statistical signifi-
cance" 
M of Extract for 
50% inhibiiion fl 
70.0 ± 28.1 
822.6 ± 260.4 
p < 0.05 
Log 1o values 
1.73 ± 0.2 
2.83 ± 0.2 
p < 0.01 
" Combined protein and carbohydrate contents for 2 ether extracts 
and 2 sonicates of each organism required for 50% inhibition of antibody 
activity (± S.E.). . 
" Statistical significance by the unpaired, two-tailed t-test. 
both cases) but not for Pityrosporum, perhaps because of 
greater variability in the results obtained with the latter. 
As shown in Table II, heating serum to 56°C for '/2 11.1' 
significantly reduced the amount of C3 deposited on the surface 
of both yeasts using either normal or C2-deficient serum. 
Protein, Carbohydrate, and Antigenic Contents of Candida 
and Pityrosporum Extracts 
As shown in Table IV, extracts of both organisms contained 
comparable protein contents, whereas those of Candida con-
tained significantly more carbohydrate. This factor resulted in 
lower protein to carbohydrate ratios for extracts of Candida 
than for those of Pityrosporum. Antigenic contents of the 
extracts were measured using inhibition of antibody activity of 
pooled human serum against the organisms in an ELISA system 
as described under Materials and Methods. The results dem-
onstrated that Candida appears to have a significantly higher 
content of antigen than does Pityrosporum (Table V), a finding 
compatible with our previous studies using the lymphocyte-
transformation system [5]. 
DISCUSSION 
These experiments indicate that the two yeasts, C. albicans 
and P. orbiculare, appear to have approximately equal abilities . 
to activate complement using either the rabbit RBC hemolytic 
system to measure alternative pathway activity left in human 
serum after incubation with the organisms or measurement of 
C3 deposition on the yeast .surface using an ELISA system. 
Complement-activating ability appeared to be comparable for 
the two organisms in both systems using either normal human 
serum or serum with a nonfunction'al classical pathway because 
of C2 deficiency or the addition of Mg-EGT A. In addition, these 
studies have demonstrated that extracts of Candida contain 
more carbohydrate and antigenic activity than do those of 
Pityrosporum. 
Many microorganisms that are pathogenic for humans initi-
ate complement activation via the alternative pathway. These 
include: (a) other Candida species in addition to C. albicans 
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[10]; (b) Cryptococcus neoformans [11]; (c) Paracoccidioides 
brasiliensis [12]; (d) Streptococcus pneumonia [13]; and (e) the 
sindbis virus [14]. In addition, complement activation has been 
suggested as a possible cause of inflammation in acne [15]. 
Finally, complement activation, particularly that occurring via 
the alternative pathway, has been demonstrated to be impor-
tant in the defense against experimental intravascular infections 
with C. albicans [16] and pneumococci [17]. Whether or not 
this process is really important in the host defense against these 
pathogens causing human disease is unclear. This situation is 
comparable to the status of alternative pathway activation by 
small molecules as a cause of some cases of asthma-an attrac-
tive hypothesis but without solid evidence backing it [18]. 
The results of the present investigation indicate that the lack 
of inflammation in the lesions of tinea versicolor is not due to 
the inability of the causative organism, P. orbiculare, to acti-
vate complement. This organism is approximately as capable 
in initiating complement activation by both pathways as is C. 
albicans, a producer of highly inflammatory cutaneous lesions. 
This finding is interesting inasmuch as Pityrosporum appears 
to contain significantly less extractable carbohydrate and anti-
genic material than does Candida. The ability to activate 
complement is obviously not a property singularly sufficient for 
an infecting organism to produce inflammatory skin lesions. 
Although in biopsies of Candida- and Pityrosporum-infected 
skin in humans the organisms are generally found at the same 
locations, i.e., confined to the stratum corneum [2,19], it is 
possible that a greater capacity of Candida for deeper invasion 
through the stratum corneum may be the reason for the differ-
ences in inflammation produced by the two organisms. Evi-
dence to support such an explanation has been generated in 
studies of experimental cutaneous infections of mice produced 
by C. albicans and other Candida species [3]. In addition, it is 
possible that Pityrosporum does not release soluble comple-
ment-activating factors that can diffuse across the stratum 
corneum to encounter a source of activatable complement. 
However, an alternative explanation is that some factor instead 
of or in addition to complement activation is important for the 
production of inflammation in superficial fungal infections. 
Differences in the quantity of antigen present and the ability to 
elicit immunologic reactions could account for the differences 
in inflammatory potential of these two organisms, as we have 
suggested previously [5]. 
The authors thank Dr. Susan Koethe (Medical College of Wisconsin, 
Milwaukee, Wisconsin) for the gift of the C2-deficient serum and 
Victoria Gollish for typing the manuscript. 
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Antizyme Release Is an Early Event in Ornithine Decarboxylase 
Induction by Hair Plucking* 
JEANNE LESIEWICZ, PH.D. AND LOWELL A. GOLDSMITH, M.D. 
Division olDennatology, Departrnent of Jltfedicin e, Dulle University Medical Center, Durham, North Carolina, U.S.A. 
Plucking of hair from the dorsal skin of rats resulted 
in a rapid decrease in ornithine decarboxylase (ODe) 
activity. A significant loss of activity did not occur in 
other skin enzymes under the same conditions and in 
vivo incorporation of [3H]-leucine in skin was not sig-
nificantly decreased 60 min immediately following hair 
plucking. Treatment of ODe enzyme preparations with 
10% (NILhSo', resulted in recovery of approximately 
75% greater ODe activity than in untreated samples, 
suggesting the presence of an inhibitor (antizyme). ODe 
inhibitor was detected in plucked skin; inhibitor levels 
increased after treatment of plucked skin extracts with 
10% (NH4 hSo',. 
In the rat, hair growth occurs in a cyclic manner. P lucking of 
hair during the telogen phase induces high levels of ornithine 
decarboxylase (L-ornithine carboxylase, Ee 4 .1.1.17) (ODe) [1] 
within 4 hr [2]. However, during the 60 'min immediately 
following hail' plucking ODe activity is observed to decrease 
[1,3]. The cause of this initial loss of ODe enzyme activity is 
the ' subject of this report. 
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Abbreviations: 
DDT: dithiothre ito l 
EDTA: (ethylened initrilol-tetraacetic acid, disod ium salt 
ODC: ornithine decarboxylase 
PLP: pyridoxal-5' -phosphate 
TCA: trichloroacetic acid 
Tris: trihydroxyaminomethane 
MATERIALS AND METHODS 
Ch.emicals 
Trihydroxyaminomethane (Tris) , pyridoxal-5'-phosphate (PLP), and 
cycloheximide, were purchased from Sigma Chemical Co., St. Louis, 
Missouri. DL-[l-"'C]-ornithine (51.2 mC/ mmol), L-[4,5-"H]-leucine (12 
Ci/mmol) , [1,4-'4C]-putrecine (89.9 mCi/mmol), phenethylamine, and 
Aquasol II were from New England Nuclear, Boston, Massachusetts. 
Enzyme-grade sucrose and ultrapure ammonium sulfate were fTom 
Schwartz-Mann, Spring Valley, New York. Dithiothreitol (OTT) was 
from Bachem Feinchemikalien, L iesta l, Switzerland. Biogel-PlOO was 
obtained fTom Bio-Rad Laboratories, Richmond, California . 
Anim.als 
Juvenile male CD strain rats weighing 80-100 g (24-28 days old) 
were obtained from Charles R iver Breeding Laboratories, Wilmington, 
Massachusetts. For ODC enzyme studies the animals were used in the 
early anagen phase of hair growth, which was defined as dorsal skin fo r 
which the most ventral edge of a patch was within 1 cm of the 
discernib le border of new hair el·up tion. For inhibitor studies, animals 
in the telogen phase were used. This phase was defined as skin for 
which no border of new hair growth was detected on the an imal's 
dorsum. 
Time Co u.rse of Plucking R esponse 
Animals were anesthesized with ether and the hair plucked from 
their dorsal skin in patches 60, 45, 30, 15, 5, and 0 (immediately) min 
before death by decapitation. Hair plucking was accomplished using 
hemostat forceps which had thin-walled rubber tubing forced over the 
ends. The hair could then be grasped t ightly a nd jerked free in clumps. 
A 2.5 x 2.5 cm skin patch can be plucked bare in 15-20 sec by this 
method. The skin patches were excised, cleaned of underlying muscll-
lature, weighed, and homogenized 1:9 (weight:volume) in ODe buffer 
(10 mM Tris pH 7.0, 0.5 mM EDTA pH 7.0, 0.01 mM PLP, and 5 mM 
DTT) as previously described [2]. ODC assays a nd turbidimetric pro-
tein determinations were performed as previously described [3]. One 
uni t of ODC activity is capable of releasing 1 Ilmol "'COz/hr. 
Response of Other Shin Enzym.es to Hair Pluching 
Animals were anesthesized with ether and the hair plucked from one 
half of their dorsal skin 60 and 0 min before death by decapitation. The 
